CSBR vs DAL · P/E 16, rev $56.9M vs P/E 12, rev $61.64B
Champions Oncology Inc (CSBR) versus Delta Air Lines Inc (DAL) — a side-by-side from cached financials, not a winner call.
Champions Oncology Inc (CSBR) is a biotechnology company listed on US.
Delta Air Lines Inc (DAL) is a airlines company listed on US. It is led by Ed Bastian.
Latest reported CSBR revenue for 2025-04-30 was $56.9M. Net income was $4.7M. CSBR currently screens at market cap $99.8M and trailing P/E 16.0.
Latest reported DAL revenue for 2024-12-31 was $61.64B. Net income was $3.46B. Revenue was up 6.2% from 2023-12-31 to 2024-12-31. DAL currently screens at market cap $52.18B and trailing P/E 11.6.
CSBR currently screens at market cap $99.8M and trailing P/E 16.0. DAL currently screens at market cap $52.18B and trailing P/E 11.6.
Not investment advice. Open the CSBR and DAL stock pages for the full models.
Not investment advice.